ER Pharmatech Co.,LTD

olaparib

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one;AZD2281;1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine;

• CAS NO :

  763113-22-0

• EC NO :

• Molecular Formula :

  C₂₄H₂₃FN₄O₃

• Molecular Weight :

  434.4628

• Main Specifications :

  99%

• InChI :

  InChI=1/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30)

• Packing :

  As customer request

• Product description :

  Product Name: Olaparib Synonyms: AZD2281(olaparib);4-(3-(1-(cyclopropanecarbonyl)piperazine-4-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one;Olaparib-D8;Olaparib, 99%, PARP inhibitor CAS: 763113-22-0 MF: C24H23FN4O3 MW: 434.469 EINECS: 642-941-5 Density: 1.43 Chemical Properties: White Solid Uses: Olaparib is a potent poly(ADP-ribose) polymerase (PARP) inhibitor. Olaparib has been shown to induce significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Recent studies show that Olaparib increases radiosensitivity of a lung tumor xenograft, making it a potential candidate for use in combination with radiotherapy.

• Uses :

  Olaparib is a potent poly(ADP-ribose) polymerase (PARP) inhibitor. Olaparib has been shown to induce significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Recent studies show that Olaparib increases radiosensitivity of a lung tum

• Molecular Structure :